Aprea Therapeutics, Inc. APRE Q1 2025 earnings
Reported May 14, 2025 · Before market open
Revenue$162.5K
EPS-$0.66Miss by $0.01
EPS estimate-$0.65
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$253.0K
EPS estimate-$0.23
Versus estimates
Revenue
Diluted EPS
Ask the moment Aprea Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aprea Therapeutics, Inc. report Q1 2025 earnings?
- Aprea Therapeutics, Inc. (APRE) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Aprea Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Aprea Therapeutics, Inc. reported revenue of $162.5K and eps of $-0.66 for Q1 2025.
- Did Aprea Therapeutics, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.65 by $0.01.
- How did Aprea Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 57.3% from $380.6K a year earlier and eps grew 1.5% from $-0.67.
- Where can I find Aprea Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-007667) directly on SEC EDGAR. The filing index links above go to sec.gov.